Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $2 |
| % Growth | 4.3% | -6% | 27.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $3 | $3 | $3 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | $3 | $2 | $2 |
| Operating Expenses | $3 | $3 | $3 | $3 |
| Operating Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -4.3% | -8.2% | 9.5% | -6.4% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$0 | $0 | -$0 |
| Tax Expense | -$0 | -$0 | $0 | -$0 |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -4.6% | -8% | 9% | -6.4% |
| EPS | -0.53 | -0.89 | 1.1 | -0.62 |
| % Growth | 40.4% | -180.9% | 277.4% | – |
| EPS Diluted | -0.53 | -0.89 | 0.92 | -0.62 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -4.2% | -7.7% | 9.9% | -5.8% |